Aggressive Lymphomas
Conference Coverage
FDA panel leans toward more robust breast implant surveillance
SILVER SPRING, MD. – Amid concern over two breast implant complications – anaplastic large cell lymphoma and autoimmune symptoms – an FDA panel...
Conference Coverage
Therapeutic dosing of busulfan helps reduce relapse in ASCT
HOUSTON - Pharmacokinetic-directed therapeutic dose monitoring of busulfan used in combination with cyclophosphamide and etoposide appears to...
News
Priority review granted to lenalidomide for FL, MZL
Celgene is seeking approval for lenalidomide in combination with rituximab to treat previously treated follicular lymphoma or marginal zone...
Feature
Barriers to CAR T use in the spotlight at first European meeting
European approvals of CAR T-cell therapy are prompting a closer look at economic issues, outcomes data, and future directions.
From the Journals
Researchers characterize new subtype of high-grade DLBCL
Patients with this subtype had distinct molecular features and poor prognosis.
From the Journals
Few DLBCL patients benefit from nivolumab
Just 10 of 121 patients responded to nivolumab in a phase 2 trial and researchers aren’t sure why this particular group of patients responded.
From the Journals
Anthracyclines, bendamustine are options for grade 3A follicular lymphoma
A CVP chemotherapy regimen performed poorly compared with anthracycline-based chemotherapy in advanced stage follicular lymphoma.
From the Journals
Ibrutinib-MTX-rituximab combo shows promise in CNS lymphoma
The researchers proposed an 840-mg dose of ibrutinib in future studies.
Conference Coverage
Applying ECHELON-2 results to clinical practice
LA JOLLA, CALIF. – At the annual T-cell Lymphoma Forum, physicians discussed how the ECHELON-2 trial may affect clinical practice.
Conference Coverage
Novel bispecific CAR shows promise in B-cell malignancies
SAN DIEGO – This is the first in-human study of a bispecific loop CAR in the United States.
From the Journals
Imaging, radiotherapy clarified in new PMBCL guidelines
The new good practice paper from the British Society for Haematology also addresses fertility preservation.